Journal article
Vaccine Effectiveness of non-adjuvanted and adjuvanted trivalent inactivated influenza vaccines in the prevention of influenza-related hospitalization in older adults: A pooled analysis from the Serious Outcomes Surveillance (SOS) Network of the Canadian Immunization Research Network (CIRN)
Abstract
BACKGROUND: Influenza vaccines prevent influenza-related morbidity and mortality; however, suboptimal vaccine effectiveness (VE) of non-adjuvanted trivalent inactivated influenza vaccine (naTIV) or quadrivalent formulations in older adults prompted the use of enhanced products such as adjuvanted TIV (aTIV). Here, the VE of aTIV is compared to naTIV for preventing influenza-associated hospitalization among older adults.
METHODS: A test-negative …
Authors
Pott H; Andrew MK; Shaffelburg Z; Nichols MK; Ye L; ElSherif M; Hatchette TF; LeBlanc J; Ambrose A; Boivin G
Journal
Vaccine, Vol. 41, No. 42, pp. 6359–6365
Publisher
Elsevier
Publication Date
October 2023
DOI
10.1016/j.vaccine.2023.08.070
ISSN
0264-410X